Literature DB >> 3104052

Pancreatic secretion in the rat influenced by the low molecular weight serine proteinase inhibitor Gabexate mesilate.

V Keim, B Göke.   

Abstract

The effect of intravenous or intragastric administration of the synthetic proteinase inhibitor Gabexate mesilate (GM) on the pancreas of rats was investigated. Infused intravenously at 4 mg kg-1 h-1, GM inhibited both basal or cerulein (0.2 microgram kg-1 h-1)-stimulated pancreatic protein secretion. Intracellular transport and secretion of newly synthesized pancreatic enzymes was not influenced by intravenous infusion of GM. Intragastric administration of GM (400 mg kg-1) on four consecutive days increased pancreatic wet weight, protein and enzyme content of the gland. A preferential increase of proteinases above glucosidases was observed. Pancreatic lobules from inhibitor-treated rats released 30% less amylase in response to cerulein or carbachol when the rate of discharge was expressed in percent of initial content. Expressed in ku amylase/microgram DNA secretion rate was two-fold higher than in controls. In pancreatic duct cannulated rats GM (400 mg kg-1 h-1), introduced intragastrically on five consecutive days, stimulated volume-bicarbonate and protein secretion rate, the secretory response on the fifth day being significantly higher than on the first day. Enzyme pattern in pancreatic juice changed characteristically: mainly the amount of acidic proteinases increased, whereas the amount of the basic isoforms was altered only slightly.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3104052     DOI: 10.1111/j.1365-2362.1986.tb02171.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Influence of a small molecular weight proteinase inhibitor, gabexate mesilate (FOY), on insulin receptor function in vitro.

Authors:  R Göke; B Göke; H J Steinfelder; R Arnold
Journal:  Int J Pancreatol       Date:  1988-03

2.  Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice.

Authors:  Roberto Caronna; Loretta Diana; Italo Nofroni; Simone Sibio; Stefania Catinelli; Paolo Sammartino; Piero Chirletti
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

3.  Dissociation of CCK-8-induced fluid secretion from protein secretion by ion-transport blockers in rat pancreas.

Authors:  T Ishikawa; T Kanno
Journal:  Int J Pancreatol       Date:  1992-04

4.  Hepatic and pancreatic metabolism and biliary excretion of the protease inhibitor camostat mesilate.

Authors:  K Beckh; H Weidenbach; F Weidenbach; R Müller; G Adler
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec

5.  Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.

Authors:  M Otsuki; M Fujii; T Nakamura; S Tani; Y Okabayashi
Journal:  Int J Pancreatol       Date:  1995-10

6.  Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.

Authors:  J von Schönfeld; M Rünzi; H Goebell; M K Müller
Journal:  Experientia       Date:  1995-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.